Under amended guidelines, pharma firms may no longer have to appear in courts for ‘minor contraventions’ Read more
PHARMEXCIL engages in high-level meetings to discuss roadmap for India’s generic pharma exports Read more
Pharma industry leaders spotlight quality, sustainability and market diversification as export priorities for 2026 Read more